Pseudochylothorax: An unusual mode of revelation of pleural metastasis from solid tumor.
Fiche publication
Date publication
décembre 2018
Journal
Tumori
Auteurs
Membres identifiés du Cancéropôle Est :
Dr STREIT Arthur
Tous les auteurs :
Streit A, Guerrera F, Kouki M, Siat J, Lyberis P, Filosso PL, Renaud S
Lien Pubmed
Résumé
Pseudochylothorax is a rare cause of pleural effusion. Sometimes confounded with chylothorax, firm diagnosis relies on analysis of the pleural liquid: exudative liquid (protein >30 g/L, lactate dehydrogenase >200 UI/L) with a high level of cholesterol (usually >200 mg/dL), low level of triglyceride (usually <110 mg/dL), cholesterol total/triglyceride ratio >1, absence of chylomicron, and in some cases the presence of cholesterol crystals. Pseudochylothorax is secondary to tuberculosis and rheumatoid arthritis in nearly 90% of cases. Its oncologic etiologies are mainly represented by malignant hematologic disorders.
Mots clés
Pseudochylothorax, cancer, metastasis, pleural effusion, tumor
Référence
Tumori. 2018 12;104(6):NP46-NP49